BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2792395)

  • 1. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
    Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
    Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
    Trojan J; Povse N; Schröder O; Stein J
    Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological detection of faecal occult blood in colorectal cancer.
    Turunen MJ; Liewendahl K; Partanen P; Adlercreutz H
    Br J Cancer; 1984 Feb; 49(2):141-8. PubMed ID: 6696817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology.
    Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ
    Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests.
    Miyoshi H; Ohshiba S; Asada S; Hirata I; Uchida K
    Am J Gastroenterol; 1992 Jan; 87(1):67-73. PubMed ID: 1728128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding colorectal tumours with an immunological faecal occult blood test in symptomatic primary health care patients.
    Kemppainen M; Häkkinen I; Räihä I; Pomoell R; Sourander L
    Age Ageing; 1994 Sep; 23(5):365-70. PubMed ID: 7825480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.